Skip to main content

Joel Klappenbach, Ph.D.

Executive Director, Worldwide Business Development

Dr. Joel Klappenbach is Executive Director of Worldwide Business Development at Pfizer. In this role, Joel is responsible for the identification and execution of business partnerships in oncology therapeutics covering pre-clinical, clinical, and commercial phases. Joel’s work in business development is informed by his expertise in biopharmaceutical R&D spanning oncology, immunology, and neuroinflammation. Prior roles include leadership of translational biomarker development at Merck. At Merck, Joel also established a functional genomics team responsible for the functionalization and prioritization of genetic targets for therapeutic development across a range of disease areas. Joel holds a Ph.D. in Microbiology & Molecular Genetics from Michigan State University and a B.S. from the University of Puget Sound.